SPFI Reports Today With Options Leaning Bullish and Insider Sales Unresolved
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
South Plains Financial reaches its Q3 earnings release today with options markets positioned unusually bullishly, even as the insider-selling overhang documented in the run-up to this print remains the dominant fundamental question.
The clearest positioning signal is in options. Call demand has overtaken puts by a wide margin, with the put/call ratio at 0.18, nearly two standard deviations below its 20-day average of 0.24. That is among the most bullish options readings of the past year for this stock. The stock itself has drifted flat over the past month, closing at $43.93, up about 2% on the week, which puts it modestly below the levels where directors sold in July and August. Short interest has eased, now at roughly 3.3% of free float after falling 12% over the past week, and borrow availability is extremely loose, with nearly all shares in the lending pool sitting idle. The borrow market carries no squeeze pressure, and the cost to borrow, though up 22% on the week, remains a negligible 0.63%. Positioning looks tilted toward optimism, rather than caution.
The analyst community has been broadly constructive, though the most recent consensus data is a few weeks old. Keefe Bruyette raised its target to $50 after Q2, Benchmark initiated with a $53 Buy in June, and Piper Sandler holds an Overweight with a $46 target after trimming from $48 following Q1. The mean target of $50.50 implies roughly 15% upside from current levels. Bulls point to the 4%-plus net interest margin, a clean credit book with non-performing assets at 0.27% of loans plus OREO, a CET1 ratio near 14.8%, and the BOH Holdings acquisition adding Houston lending capacity after its May conversion. Bears flag a securities portfolio yielding 3.34% that limits asset repricing, rising criticized loans at $101 million (3.2% of the portfolio), softer fee income since the insurance sale, and integration risk from BOH. The valuation sits at about 10.7 times trailing earnings and 1.18 times book, neither stretched nor deeply discounted.
The ownership picture is the harder question going into the print. As noted before today's release, directors sold approximately $12.8 million of stock in the 90 days to early August, all discretionary and none under a 10b5-1 plan. Director Richard Campbell sold 160,000 shares in early August at prices above today's close. Chairman and CEO Curtis Griffith's amended Schedule 13G filed in August showed his stake falling from 8.9% to 6.15%, with a 300,000-share disposition in June as the underlying transaction. On the institutional side, BlackRock added 278,617 shares as of September 30, and State Street added 140,094, providing some counterweight from passive and index flows.
The print will test whether the Q3 figures, and particularly the BOH integration's early contribution to net interest income and loan growth, are strong enough to close the gap between the stock's current price and analyst targets that sit roughly 15% higher.
Stocks in this article
See the live data behind this article on ORTEX.
Open SPFI on ORTEX →How this article was generated
- Generated
- 23 Oct 2026, 04:22
- Data as of
- 23 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.